AllSight
Companies · MRVI · Pharmaceutical Preparations

MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) stock — financials & valuation

Key numbers for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 34/100 — a percentile rank of MARAVAI LIFESCIENCES HOLDINGS, INC.’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.

Market cap$1.1B
P / S5.3×
EV / EBITDA-56.2×
Gross margin34.9%
Operating margin-56.1%
Net margin-65.2%
Return on equity-37.8%
ROIC-25.3%
Revenue growth-5.0%
Debt / equity0.9×
Dividend yield0.0%

Is MARAVAI LIFESCIENCES HOLDINGS, INC. overvalued? P/S looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from MARAVAI LIFESCIENCES HOLDINGS, INC.’s own financial statements and shown as context, never as advice.

Aug 6, 2026
Revenue and adjusted EPS beat subdued expectations; COVID boost fades
Related companies in Pharmaceutical Preparations
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact